DOXY

This brand name is authorized in France, Hong Kong, Israel, New Zealand, United States

Active ingredients

The drug DOXY contains one active pharmaceutical ingredient (API):

1 Doxycycline
UNII 19XTS3T51U - DOXYCYCLINE HYCLATE

Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis.

Read about Doxycycline

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DOXY Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01AA02 Doxycycline J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 61722191, 67061569
Country: HK Department of Health Drug Office Identifier(s): 38107, 42036
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3532
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2731, 2733
Country: US FDA, National Drug Code Identifier(s): 51662-1402, 52584-028, 63323-130

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.